On October 30, 2023, Catalyst Biosciences, Inc. closed the transaction. The company has received 5,000,000 pursuant to Regulation D and included participation from single investor.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.93 USD | -1.24% |
|
+21.77% | +55.81% |
- Stock Market
- Equities
- CBIO Stock
- News Catalyst Biosciences
- Catalyst Biosciences, Inc. announced that it has received $4.999815 million in funding from GNI USA, Inc.